Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Hedge Funds

ValueAct Capital Boosts Stake In Valeant Pharmaceuticals As Stock Skids

by feedproxy.google.com posted 1year ago 219 views
Jeff Ubben's activist hedge fund ValueAct Capital has raised its stake in embattled Canadian drug company Valeant Pharmaceuticals just days after Bill Ackman’s Pershing Square threw in the towel and sent the stock to eight-year lows.read more